Single‐Arm Meta‐Analysis and Systematic Review on Clinical Cure of Chronic Hepatitis B After Haematopoietic Stem Cell Transplantation: Immunoregulatory Mechanisms and Clinical Translational Insights
Journal of Viral Hepatitis · 2026
DOI: 10.1111/jvh.70114 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Viral Hepatitis, 2026. Verfasst von He Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center of Peking University People's H…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Capital's Funds for Health Improvement and Research (CFH).
Abstract (Originalsprache)
The quest for a functional cure for chronic hepatitis B (CHB) remains an elusive objective. Haematopoietic stem cell transplantation (HSCT) may elicit viral clearance by immunological remodelling in recipients with positive HBsAg; however, the factors that determine its effectiveness are yet unknown. The aim of the study is to assess HSCT‐induced hepatitis B surface antigen (HBsAg) seroclearance rates and identify immunological mechanisms and combination therapy strategies through meta‐analysis and systematic review. In this study, nine trials (308 patients) were subjected to single‐arm meta‐analysis (R4.4.2 ‘meta’ package) in accordance with PRISMA/Cochrane criteria. Heterogeneity was addressed via random‐effects models ( I 2 = 87.1%). Subgroup analysis accounted for donor HBsAb/recipient HBeAg impacts. The total HBsAg clearance rate was 26% (95% CI: 14%–39%), greater than that of standard therapies. Notably, HBsAb‐positive donors had significantly enhanced clearance (55% vs. 8%, p < 0.01). HBeAg‐negative recipients fared better (29% vs. 2%). In patients who achieved HBsAg loss, HBsAb‐positive donors and HBeAg‐negative recipients are the most prevalent types (10/11). Sensitivity analyses confirmed robustness and publication bias was nonsignificant (Egger's p = 0.271). In conclusion, HSCT demonstrates the potential for functional cure in CHB, providing valuable insights into new immunological therapeutic strategies. More importantly, it serves as a powerful paradigm for identifying the immunological prerequisites for cure, informing the development of safer, targeted immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking University People's Hospital, Peking University Hepatology Institute, Infectious Disease and Hepatology Center of Peking University People's Hospital, Beijing Key Laboratory of Hepatitis C and Immunotherapy for L…
ORCID-Profile: He Ma, JiaRui Zheng, LinXiang Huang, Bo Feng
Förderung
- Capital's Funds for Health Improvement and Research (CFH)
Zitieren
APA
Ma, H., Zheng, J., Huang, L., Qiu, Z., Wang, Z., Xie, Y., & Feng, B. (2026). Single‐Arm Meta‐Analysis and Systematic Review on Clinical Cure of Chronic Hepatitis B After Haematopoietic Stem Cell Transplantation: Immunoregulatory Mechanisms and Clinical Translational Insights. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70114
Vancouver
Ma H, Zheng J, Huang L, Qiu Z, Wang Z, Xie Y, et al. Single‐Arm Meta‐Analysis and Systematic Review on Clinical Cure of Chronic Hepatitis B After Haematopoietic Stem Cell Transplantation: Immunoregulatory Mechanisms and Clinical Translational Insights. Journal of Viral Hepatitis. 2026. doi:10.1111/jvh.70114
BibTeX
@article{Ma2026,
author = {Ma, He and Zheng, JiaRui and Huang, LinXiang and Qiu, ZiXuan and Wang, ZiLong and Xie, YanDi and Feng, Bo},
title = {Single‐Arm Meta‐Analysis and Systematic Review on Clinical Cure of Chronic Hepatitis B After Haematopoietic Stem Cell Transplantation: Immunoregulatory Mechanisms and Clinical Translational Insights},
journal = {Journal of Viral Hepatitis},
year = {2026},
doi = {10.1111/jvh.70114}
}
EUVIMED